Načítá se...
Case Report: Glatiramer Acetate–Induced Serum Sickness
Multiple sclerosis (MS) is a central nervous system demyelinating disease with a prevalence of approximately 400,000 individuals in the United States. Glatiramer acetate is a frequently prescribed disease-modifying therapy used for the management of relapsing forms of the disease. A 40-year-old woma...
Uloženo v:
| Vydáno v: | Int J MS Care |
|---|---|
| Hlavní autor: | |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
The Consortium of Multiple Sclerosis Centers
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5649350/ https://ncbi.nlm.nih.gov/pubmed/29070967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7224/1537-2073.2016-072 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|